Current and Emerging Pharmacotherapies for Primary CNS Lymphoma
Primary central nervous system lymphoma (PCNSL) constitutes a rare group of extranodal non-Hodgkin's lymphoma (NHL) primarily of B cell origin. It occurs in both immuno-competent and immune-compromised patients. High dose methotrexate (HD-MTX) based chemotherapy is the standard therapy. Chemoth...
| Autors principals: | , |
|---|---|
| Format: | Article |
| Idioma: | English |
| Publicat: |
SAGE Publishing
2012-01-01
|
| Col·lecció: | Clinical Medicine Insights: Oncology |
| Accés en línia: | https://doi.org/10.4137/CMO.S7752 |